Private equity firm profile
bValue
bValue invests in technology and growth businesses in Central and Eastern Europe, combining equity capital with operational expertise and maintaining both venture and growth portfolios.

Central and Eastern Europe
Growth
Growth strategy targets proven business models and profitability indicators. Its November 2022 strategy describes EUR 5–15 million per company, usually minority stakes, but the January 2026 Parens investment acquired a majority stake for EUR 7.05 million; structure is deal-specific. These are not universal venture-fund terms. Founder fees are not disclosed.
Healthcare & Life Sciences
Central and Eastern Europe
Sources checked
Growth strategy targets proven business models and profitability indicators. Its November 2022 strategy describes EUR 5–15 million per company, usually minority stakes, but the January 2026 Parens investment acquired a majority stake for EUR 7.05 million; structure is deal-specific. These are not universal venture-fund terms. Founder fees are not disclosed.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
bValue's growth strategy backs established businesses seeking expansion capital and operational support, alongside its venture portfolio. In January 2026 it announced a majority investment in fertility-care group Parens; founders can use the published contact email to discuss financing.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-14
bValue official sourcebValue official sourcebValue official sourcebValue official sourcebValue official sourcebValue official sourcebValue official sourceLoading recent changes…